Furthermore, longitudinal population-based studies have found higher levels of IL-6 and CRP at baseline to be associated with an increased average likelihood of depression several years later (Khandaker et al., 2014, Zalli et al., 2016). Here, IL6 is linked to depressive symptom measurement.